The latest publication by Dhara D. et al, from Prof Tom Brown's group, reports a straightforward method for synthesising antisense oligonucleotides with charge-neutral phosphotriester backbones, enabling the incorporation of diverse functional groups at multiple internal positions. These modified oligonucleotides retain strong duplex stability and splice-switching activity in vitro, with certain conjugates showing enhanced performance, highlighting their potential for improved delivery and efficacy in therapeutic applications.

Share this

Back to News & Events